- Danh mục
- Nhóm Úc – Tác nhân gây bệnh cho người, động vật và độc tố – Bản ngày 27/3/2026
Nguyên văn tiếng Anh
1. An agent/pathogen is covered by this list except when it is in the form of a vaccine. A vaccine is a medicinal product in a pharmaceutical formulation licensed by, or having marketing or clinical trial (including veterinary clinical trial) authorisation from, the regulatory authorities of either the country of manufacture or of use, which is intended to stimulate a protective immunological response in humans or animals in order to prevent disease in those to whom or to which it is administered.
2. This includes only those Avian influenza viruses of high pathogenicity as defined by the World Organization for Animal Health (OIE), the European Union (EU), or competent national regulatory bodies.
3. It is understood that limiting this control to epsilon toxin-producing strains of
Clostridium perfringens therefore exempts from control the transfer of other Clostridium perfringens strains to be used as positive control cultures for food testing and quality control.
4. Shiga toxin producing Escherichia coli (STEC) includes inter alia enterohaemorrhagic E. coli (EHEC), verotoxin producing E. coli (VTEC) or verocytotoxin producing E. coli (VTEC).
5. Excluding immunotoxins.
6. Excluding botulinum neurotoxins and conotoxins in product form meeting all of the following criteria:
- are pharmaceutical formulations designed for testing and human administration in the treatment of medical conditions;
- are pre-packaged for distribution as clinical or medical products; and
- are authorised by a state authority to be marketed as clinical or medical products.
7. The Australia Group recognizes that this organism is ubiquitous, but, as it has been acquired in the past as part of biological warfare programs, it is worthy of special caution.
8. It is the intent of Australia Group members to add to the control list strains of species of Clostridium identified as producing botulinum neurotoxin.
2. This includes only those Avian influenza viruses of high pathogenicity as defined by the World Organization for Animal Health (OIE), the European Union (EU), or competent national regulatory bodies.
3. It is understood that limiting this control to epsilon toxin-producing strains of
Clostridium perfringens therefore exempts from control the transfer of other Clostridium perfringens strains to be used as positive control cultures for food testing and quality control.
4. Shiga toxin producing Escherichia coli (STEC) includes inter alia enterohaemorrhagic E. coli (EHEC), verotoxin producing E. coli (VTEC) or verocytotoxin producing E. coli (VTEC).
5. Excluding immunotoxins.
6. Excluding botulinum neurotoxins and conotoxins in product form meeting all of the following criteria:
- are pharmaceutical formulations designed for testing and human administration in the treatment of medical conditions;
- are pre-packaged for distribution as clinical or medical products; and
- are authorised by a state authority to be marketed as clinical or medical products.
7. The Australia Group recognizes that this organism is ubiquitous, but, as it has been acquired in the past as part of biological warfare programs, it is worthy of special caution.
8. It is the intent of Australia Group members to add to the control list strains of species of Clostridium identified as producing botulinum neurotoxin.